1. Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan
   H. Okumura et al, 2016, Diseases of the Esophagus CrossRef
2. Propensity-score matched analysis to evaluate efficacy of endoscopic submucosal dissection for superficial esophageal cancer in gastrectomized patients
   Yasuhiko Hamada et al, 2022, Scientific Reports CrossRef
3. Molecular functions and significance of the MTA family in hormone-independent cancer
   Zhifeng Ning et al, 2014, Cancer and Metastasis Reviews CrossRef
4. MTA1 expression in human cancers – Clinical and pharmacological significance
   Vijaya Lakshmi Malisetty et al, 2017, Biomedicine & Pharmacotherapy CrossRef
5. Histone Modifying Enzymes as Targets for Therapeutic Intervention in Oesophageal Adenocarcinoma
   Oliver J. Pickering et al, 2021, Cancers CrossRef
6. Vorinostat differentially alters 3D nuclear structure of cancer and non-cancerous esophageal cells
   Vivek Nandakumar et al, 2016, Scientific Reports CrossRef
7. Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma
   Li-Si Zeng et al, 2016, Aging CrossRef
8. Clinical implications of MTA proteins in human cancer
   Ekjot Kaur et al, 2014, Cancer and Metastasis Reviews CrossRef
9. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways
   Bin Zhang et al, 2018, Molecular Medicine Reports CrossRef
10. Clinical significance of HDAC1, -2 and -3 expression levels in esophageal squamous cell carcinoma
    Huiwu Li et al, 2020, Experimental and Therapeutic Medicine CrossRef
11. High yield reproducible rat model recapitulating human Barrett’s carcinogenesis
    Daisuke Matsui et al, 2017, World Journal of Gastroenterology CrossRef
12. Emerging therapeutic targets in esophageal adenocarcinoma
    Puja Gaur et al, 2016, Oncotarget CrossRef